XGIMI(SH:688696)2023-04-27 16:00Financial Performance - The total revenue for Q1 2023 was ¥883,693,767.84, representing a decrease of 12.75% compared to the same period last year [6] - The net profit attributable to shareholders was ¥52,193,828.12, down 57.03% year-over-year [6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥41,640,805.94, a decline of 59.44% compared to the previous year [6] - The basic earnings per share for the period was ¥0.75, reflecting a decrease of 56.79% year-over-year [6] - Total operating revenue for Q1 2023 was approximately ¥883.69 million, a decrease of 12.74% from ¥1,012.89 million in Q1 2022 [21] - Net profit for Q1 2023 was approximately ¥51.99 million, a decline of 57.16% compared to ¥121.47 million in Q1 2022 [22] - Basic and diluted earnings per share for Q1 2023 were both ¥0.75, down from ¥1.74 in Q1 2022 [23] - The company reported a total comprehensive income of approximately ¥50.22 million in Q1 2023, down from ¥120.15 million in Q1 2022 [22] Cash Flow - The net cash flow from operating activities was ¥81,747,819.31, with no applicable year-over-year comparison [6] - Cash flow from operating activities generated a net inflow of approximately ¥81.75 million in Q1 2023, compared to a net outflow of ¥136.09 million in Q1 2022 [25] - Cash flow from investment activities showed a net inflow of approximately ¥17.41 million in Q1 2023, a significant improvement from a net outflow of ¥412.07 million in Q1 2022 [25] - Cash flow from financing activities resulted in a net inflow of approximately ¥250.96 million in Q1 2023, compared to ¥51.23 million in Q1 2022 [25] - The beginning cash and cash equivalents balance for Q1 2023 was $1,413,672,018.70, compared to $1,038,928,264.01 in Q1 2022, indicating a year-over-year increase [26] - The ending cash and cash equivalents balance for Q1 2023 was $1,762,694,587.65, significantly up from $540,350,315.64 in Q1 2022, reflecting strong cash flow management [26] Assets and Liabilities - Total assets at the end of the period were ¥5,537,199,645.50, an increase of 4.75% from the end of the previous year [7] - As of March 31, 2023, the total current assets of the company amounted to RMB 4,159,494,621.73, an increase from RMB 3,913,684,476.85 at the end of 2022, reflecting a growth of approximately 6.3% [15] - The total liabilities of the company as of March 31, 2023, were RMB 2,328,509,999.28, compared to RMB 2,147,190,643.25 at the end of 2022, indicating an increase of approximately 8.4% [18] - The company's total equity reached RMB 3,208,689,646.22, up from RMB 3,138,871,271.28, marking an increase of about 2.2% [18] - The inventory value as of March 31, 2023, was RMB 1,260,260,679.39, compared to RMB 1,184,462,084.65 at the end of 2022, showing an increase of approximately 6.4% [17] - The accounts receivable decreased to RMB 131,502,630.70 from RMB 324,802,959.96, reflecting a decline of about 59.5% [15] - The company's non-current assets totaled RMB 1,377,705,023.77, slightly up from RMB 1,372,377,437.68, indicating a marginal increase of about 0.2% [17] - The company's short-term borrowings were recorded at RMB 182,088,303.42, with no previous short-term borrowings reported [18] - The company's retained earnings increased to RMB 1,030,951,822.58 from RMB 978,757,994.46, representing a growth of approximately 5.3% [18] Research and Development - Research and development expenses totaled ¥99,431,592.36, accounting for 11.25% of total revenue, an increase of 1.99 percentage points [7] - The company’s research and development expenses increased to approximately ¥99.43 million in Q1 2023, up from ¥93.77 million in Q1 2022 [21] Tax and Accounting - The company’s tax expenses for Q1 2023 were approximately ¥10.18 million, a decrease from ¥20.06 million in Q1 2022 [22] - The company has adopted new accounting standards starting in 2023, which may impact financial reporting going forward [26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,082 [12]